DIAZEPAM INTERACTION WITH ANTI-TUBERCULOSIS DRUGS

被引：61

作者：

OCHS, HR ^{[1
]}

GREENBLATT, DJ ^{[1
]}

ROBERTS, GM ^{[1
]}

DENGLER, HJ ^{[1
]}

机构：

[1] TUFTS UNIV,NEW ENGLAND MED CTR,DIV CLIN PHARMACOL,BOSTON,MA 02111

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 05期

关键词：

D O I：

10.1038/clpt.1981.94

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：671 / 678

页数：8

共 18 条

[1] CLINICAL PHARMACOKINETICS OF RIFAMPICIN [J].

ACOCELLA, G .

CLINICAL PHARMACOKINETICS, 1978, 3 (02) :108-127

[2]

BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470

[3]

EDWARDS OM, 1974, LANCET, V2, P549

[4] ENTRY OF DIAZEPAM AND ITS MAJOR METABOLITE INTO CEREBROSPINAL-FLUID [J].

GREENBLATT, DJ ;

OCHS, HR ;

LLOYD, BL .

PSYCHOPHARMACOLOGY, 1980, 70 (01) :89-93

[5] DRUG-THERAPY - CLINICAL PHARMACOKINETICS .1. [J].

GREENBLATT, DJ ;

KOCHWESER, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) :702-705

[6] DRUG-THERAPY - CLINICAL PHARMACOKINETICS .2. [J].

GREENBLATT, DJ ;

KOCHWESER, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (19) :964-970

[7] DIAZEPAM DISPOSITION DETERMINANTS [J].

GREENBLATT, DJ ;

ALLEN, MD ;

HARMATZ, JS ;

SHADER, RI .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :301-312

[8]

GREENBLATT DJ, 1978, CLIN CHEM, V24, P1838

[9] PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM IN HUMANS [J].

GREENBLATT, DJ ;

SHADER, RI ;

FRANKE, K ;

MACLAUGHLIN, DS ;

HARMATZ, JS ;

ALLEN, MD ;

WERNER, A ;

WOO, E .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (01) :57-63

[10]

LAROUSSE C, 1980, INT J CLIN PHARM TH, V18, P163

← 1 2 →